Gene-environment interaction with smoking for increased non-muscle-invasive bladder cancer tumor size

被引:6
作者
Lipunova, Nadezda [1 ,2 ,3 ]
Wesselius, Anke [3 ]
Cheng, Kar K. [4 ]
Van Schooten, Frederik-Jan [5 ]
Bryan, Richard T. [1 ]
Cazier, Jean-Baptiste [1 ,2 ]
Zeegers, Maurice P. [1 ,3 ]
机构
[1] Univ Birmingham, Inst Canc & Genom Sci, Birmingham, W Midlands, England
[2] Univ Birmingham, Ctr Computat Biol, Birmingham, W Midlands, England
[3] Maastricht Univ, Dept Complex Genet, Maastricht, Netherlands
[4] Univ Birmingham, Inst Appl Hlth Res, Birmingham, W Midlands, England
[5] Maastricht Univ, Dept Genet & Mol Toxicol, Maastricht, Netherlands
关键词
Bladder cancer; gene-environment interaction (GxE); smoking; SNP; tumor size; NAT2 SLOW ACETYLATION; PHOSPHODIESTERASE INHIBITORS; FUNCTIONAL ANNOTATION; GSTM1; NULL; RISK; GENOTYPE; CELLS; EPIDEMIOLOGY; AMPHIREGULIN; ASSOCIATION;
D O I
10.21037/tau-19-523
中图分类号
R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
摘要
Background: Urinary bladder cancer (UBC) is one of few cancers with an established gene-environment interaction (GxE) with smoking. However, it is unknown whether the interaction with tobacco use is present non-muscle invasive bladder cancer (NMIBC) and characteristics of prognostic relevance. We aimed to investigate if smoking status and/or smoking intensity interact with the effect of discovered variants on key NMIBC characteristics of tumor grade, stage, size, and patient age within the Bladder Cancer Prognosis Programme (BCPP) cohort. Methods: Analyzed sample consisted of 546 NMIBC patients with valid smoking data from the BCPP. In a previous genome-wide association study (GWAS), we have identified 61 single nucleotide polymorphisms (SNPs) potentially associated with the NMIBC characteristics of tumor stage, grade, size, and patient age. In the current analysis, we have tested these SNPs for GxE with smoking. Results: Out of 61 SNPs, 10 have showed suggestion (statistical significance level of P<0.05) for GxE with NMIBC tumor size rs35225990, rs188958632, rs180910528, rs74603364, rs187040828, rs144383242, rs117587674, rs113705641, rs2937268, and chromosome 14:38247577. All SNPs were located across loci of 1p31.3, 3p26.1, 6814.1, 14821.1, and 13814.13. In addition, two of the tested polymorphisms were suggestive for interaction with smoking intensity (chromosome 14:38247577 and rs2937268). Conclusions: Our study suggests interaction between genetic variance and smoking behavior for increased NMIBC tumor size at the time of diagnosis. Further replication is required to validate these findings.
引用
收藏
页码:1329 / +
页数:11
相关论文
共 45 条
[1]   Selective Inhibitors of Phosphodiesterase 4B (PDE-4B) May Provide a Better Treatment for CNS, Metabolic, Autoimmune, and Inflammatory Diseases [J].
Abdel-Magid, Ahmed F. .
ACS MEDICINAL CHEMISTRY LETTERS, 2017, 8 (11) :1132-1133
[2]   Phosphodiesterase type 4 inhibition enhances nitric oxide- and hydrogen sulfide-mediated bladder neck inhibitory neurotransmission [J].
Agis-Torres, Angel ;
Recio, Paz ;
Elvira Lopez-Oliva, Maria ;
Pilar Martinez, Maria ;
Victoria Barahona, Maria ;
Benedito, Sara ;
Bustamante, Salvador ;
Angel Jimenez-Cidre, Miguel ;
Garcia-Sacristan, Albino ;
Prieto, Dolores ;
Fernandes, Vitor S. ;
Hernandez, Medardo .
SCIENTIFIC REPORTS, 2018, 8
[3]   The Ensembl gene annotation system [J].
Aken, Bronwen L. ;
Ayling, Sarah ;
Barrell, Daniel ;
Clarke, Laura ;
Curwen, Valery ;
Fairley, Susan ;
Banet, Julio Fernandez ;
Billis, Konstantinos ;
Giron, Carlos Garcia ;
Hourlier, Thibaut ;
Howe, Kevin ;
Kahari, Andreas ;
Kokocinski, Felix ;
Martin, Fergal J. ;
Murphy, Daniel N. ;
Nag, Rishi ;
Ruffier, Magali ;
Schuster, Michael ;
Tang, Y. Amy ;
Vogel, Jan-Hinnerk ;
White, Simon ;
Zadissa, Amonida ;
Flicek, Paul ;
Searle, Stephen M. J. .
DATABASE-THE JOURNAL OF BIOLOGICAL DATABASES AND CURATION, 2016,
[4]   EAU Guidelines on Non-Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016 [J].
Babjuk, Marko ;
Boehle, Andreas ;
Burger, Maximilian ;
Capoun, Otakar ;
Cohen, Daniel ;
Comperat, Eva M. ;
Hernandez, Virginia ;
Kaasinen, Eero ;
Palou, Joan ;
Roupret, Morgan ;
van Rhijn, Bas W. G. ;
Shariat, Shahrokh F. ;
Soukup, Viktor ;
Sylvester, Richard J. ;
Zigeuner, Richard .
EUROPEAN UROLOGY, 2017, 71 (03) :447-461
[5]   Molecular pathways in bladder cancer: Part 1 [J].
Bryan, RT ;
Hussain, SA ;
James, ND ;
Jankowski, JA ;
Wallace, DMA .
BJU INTERNATIONAL, 2005, 95 (04) :485-490
[6]   Epidemiology and Risk Factors of Urothelial Bladder Cancer [J].
Burger, Maximilian ;
Catto, James W. F. ;
Dalbagni, Guido ;
Grossman, H. Barton ;
Herr, Harry ;
Karakiewicz, Pierre ;
Kassouf, Wassim ;
Kiemeney, Lambertus A. ;
La Vecchia, Carlo ;
Shariat, Shahrokh ;
Lotan, Yair .
EUROPEAN UROLOGY, 2013, 63 (02) :234-241
[7]   Second-generation PLINK: rising to the challenge of larger and richer datasets [J].
Chang, Christopher C. ;
Chow, Carson C. ;
Tellier, Laurent C. A. M. ;
Vattikuti, Shashaank ;
Purcell, Shaun M. ;
Lee, James J. .
GIGASCIENCE, 2015, 4
[8]   The international Genome sample resource (IGSR): A worldwide collection of genome variation incorporating the 1000 Genomes Project data [J].
Clarke, Laura ;
Fairley, Susan ;
Zheng-Bradley, Xiangqun ;
Streeter, Ian ;
Perry, Emily ;
Lowy, Ernesto ;
Tasse, Anne-Marie ;
Flicek, Paul .
NUCLEIC ACIDS RESEARCH, 2017, 45 (D1) :D854-D859
[9]   Cyclic AMP-specific PDE4 phosphodiesterases as critical components of cyclic AMP signaling [J].
Conti, M ;
Richter, W ;
Mehats, C ;
Livera, G ;
Park, JY ;
Jin, C .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (08) :5493-5496
[10]   Phosphodiesterase 4 inhibitors have wide-ranging activity in B-cell malignancies [J].
Cooney, Jeffrey D. ;
Aguiar, Ricardo C. T. .
BLOOD, 2016, 128 (25) :2886-2890